Gut microbiota have been studied in relation to the pathophysiology of Parkinson’s disease (PD)
due to the early gastrointestinal symptomatology and presence of alpha-synuclein …

In the course of Parkinson's disease (PD), the enteric nervous system (ENS) and parasympathetic
nerves are amongst the structures earliest and most frequently affected by alpha‐…

Background Previous studies have reported that gut microbiota, permeability, short-chain
fatty acids (SCFAs), and inflammation are altered in Parkinson’s disease (PD), but how these …

Background Several publications have described differences in cross-sectional comparisons
of gut microbiota between patients with Parkinson's disease and control subjects, with …

Introduction Parkinson's disease (PD) is associated with neuropathological changes in
olfactory and gastrointestinal tissues, and PD patients frequently suffer from hyposmia, …

For a long time, the human lower airways were considered a sterile environment where the
presence of microorganisms, typically revealed by culturing, was interpreted as an abnormal …

Gut microbiota alterations in Parkinson’s disease (PD) have been found in several studies
and are suggested to contribute to the pathogenesis of PD. However, previous results could …

Oral retinoids and tetracyclines have a major role in acne treatment. Here, we report for the
first time the effect of isotretinoin and lymecycline therapy on the skin microbiota in cheek, …

Background The gut microbiome and its metabolites can impact brain health and are altered
in Parkinson's disease (PD) patients. It has been recently demonstrated that PD patients …

We aimed to investigate the link between serum metabolites, gut bacterial community
composition, and clinical variables in Parkinson’s disease (PD) and healthy control subjects (HC). …